TEM - Tempus AI, Inc.


51.4
-1.910   -3.716%

Share volume: 6,934,098
Last Updated: 03-03-2026
Computer Software/Services – Computer Programming And Data Processing: -0.16%

PREVIOUS CLOSE
CHG
CHG%

$53.31
-1.91
-0.04%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
50%
Profitability 35%
Dept financing 43%
Liquidity 75%
Performance 60%
Company vs Stock growth
vs
Performance
5 Days
-3.47%
1 Month
-4.01%
3 Months
-32.66%
6 Months
-34.20%
1 Year
-2.52%
2 Year
-17.44%
Key data
Stock price
$51.40
P/E Ratio 
0.00
DAY RANGE
$48.75 - $52.87
EPS 
-$1.16
52 WEEK RANGE
$36.22 - $104.32
52 WEEK CHANGE
-$3.13
MARKET CAP 
10.505 B
YIELD 
N/A
SHARES OUTSTANDING 
178.774 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
08-05-2025
BETA 
0.00
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
$6,446,771
AVERAGE 30 VOLUME 
$6,125,663
Company detail
CEO: Eric Lefkofsky
Region: US
Website: www.tempus.com
Employees: 0
IPO year: 2024
Issue type:
Market: XNAS
Industry: Computer Software/Services – Computer Programming And Data Processing
Sector: Services

We endeavor to unlock the true power of precision medicine by creating Intelligent Diagnostics through the practical application of artificial intelligence, or AI, in healthcare. Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal. We were founded by Eric Lefkofsky, originally formed under the name Bioin LLC in Delaware in August 2015 and we converted to a Delaware corporation in September 2015 under the name Bioin Inc. We changed our name to Tempus Health, Inc. later in 2015, to Tempus Labs, Inc. in 2016 and in 2023, we changed our name to Tempus AI, Inc. Our principal executive offices are located at 600 West Chicago Avenue, Suite 510 Chicago, Illinois.

Recent news